LitCovid-sample-Enju  

PMC:7253482 / 1054-1436 JSONTXT 18 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T161 5-8 RB denotes not
T162 9-13 RB denotes only
T163 14-24 JJ denotes individual
T164 25-31 NN denotes glycan
T165 32-44 NNS denotes compositions
T166 45-48 CC denotes but
T167 49-53 RB denotes also
T168 54-57 DT denotes the
T169 58-71 JJ denotes immunological
T170 72-80 NN denotes pressure
T171 81-87 IN denotes across
T172 88-91 DT denotes the
T173 92-99 NN denotes protein
T174 100-107 NN denotes surface
T175 110-123 NN denotes Glycosylation
T176 124-129 VBZ denotes plays
T177 130-131 DT denotes a
T178 132-135 JJ denotes key
T179 136-140 NN denotes role
T180 141-143 IN denotes in
T181 144-153 NN denotes shielding
T182 154-156 IN denotes of
T183 157-168 JJ denotes immunogenic
T184 169-177 NNS denotes epitopes
T185 178-180 IN denotes on
T186 181-186 JJ denotes viral
T187 187-192 NN denotes spike
T188 193-194 -LRB- denotes (
T189 194-195 NN denotes S
T190 195-196 -RRB- denotes )
T191 197-205 NNS denotes proteins
T192 207-211 RB denotes Here
T193 212-220 NNP denotes Watanabe
T194 221-223 FW denotes et
T195 224-227 FW denotes al.
T196 228-234 NN denotes report
T197 235-239 IN denotes that
T198 240-247 NNS denotes glycans
T199 248-250 IN denotes of
T200 251-262 NN denotes coronavirus
T201 263-267 NNS denotes SARS
T202 268-271 CC denotes and
T203 272-276 NNP denotes MERS
T204 277-278 NN denotes S
T205 279-287 NNS denotes proteins
T206 288-291 VBP denotes are
T207 292-307 RB denotes heterogeneously
T208 308-319 VBN denotes distributed
T209 320-323 CC denotes and
T210 324-326 VBP denotes do
T211 327-330 RB denotes not
T212 331-335 VB denotes form
T213 336-338 DT denotes an
T214 339-350 JJ denotes efficacious
T215 351-363 JJ denotes high-density
T216 364-370 JJ denotes global
T217 371-377 NN denotes shield
R157 T162 T161 arg1Of only,not
R158 T165 T162 arg1Of compositions,only
R159 T165 T163 arg1Of compositions,individual
R160 T165 T164 arg1Of compositions,glycan
R162 T170 T166 arg2Of pressure,but
R163 T166 T167 arg1Of but,also
R164 T170 T168 arg1Of pressure,the
R165 T170 T169 arg1Of pressure,immunological
R166 T170 T171 arg1Of pressure,across
R167 T174 T171 arg2Of surface,across
R168 T174 T172 arg1Of surface,the
R169 T174 T173 arg1Of surface,protein
R170 T175 T176 arg1Of Glycosylation,plays
R171 T179 T176 arg2Of role,plays
R172 T179 T177 arg1Of role,a
R173 T179 T178 arg1Of role,key
R174 T176 T180 arg1Of plays,in
R175 T181 T180 arg2Of shielding,in
R176 T181 T182 arg1Of shielding,of
R177 T184 T182 arg2Of epitopes,of
R178 T184 T183 arg1Of epitopes,immunogenic
R179 T181 T185 arg1Of shielding,on
R180 T191 T185 arg2Of proteins,on
R181 T187 T186 arg1Of spike,viral
R182 T191 T187 arg1Of proteins,spike
R183 T187 T188 arg1Of spike,(
R184 T189 T188 arg2Of S,(
R185 T190 T188 arg3Of ),(
R186 T196 T192 arg1Of report,Here
R187 T195 T193 arg1Of al.,Watanabe
R188 T195 T194 arg1Of al.,et
R189 T195 T196 arg1Of al.,report
R190 T209 T196 arg2Of and,report
R191 T209 T197 arg1Of and,that
R192 T198 T199 arg1Of glycans,of
R193 T202 T199 arg2Of and,of
R194 T201 T200 arg1Of SARS,coronavirus
R195 T201 T202 arg1Of SARS,and
R196 T205 T202 arg2Of proteins,and
R197 T205 T203 arg1Of proteins,MERS
R198 T205 T204 arg1Of proteins,S
R199 T198 T206 arg1Of glycans,are
R200 T208 T206 arg2Of distributed,are
R201 T208 T207 arg1Of distributed,heterogeneously
R202 T198 T208 arg2Of glycans,distributed
R203 T208 T209 arg1Of distributed,and
R204 T212 T209 arg2Of form,and
R205 T198 T210 arg1Of glycans,do
R206 T212 T210 arg2Of form,do
R207 T212 T211 arg1Of form,not
R208 T198 T212 arg1Of glycans,form
R209 T217 T212 arg2Of shield,form
R210 T217 T213 arg1Of shield,an
R211 T217 T214 arg1Of shield,efficacious
R212 T217 T215 arg1Of shield,high-density
R213 T217 T216 arg1Of shield,global